Cas 1013695-97-0,N-[5-Chloro-6-(quinolin-3-yloxy)-pyridine-3-yl]-4-methoxy-benzenesulfonamide

1013695-97-0

Post Buying Request

Basic information

Product Name: N-[5-Chloro-6-(quinolin-3-yloxy)-pyridine-3-yl]-4-methoxy-benzenesulfonamide
Synonyms:
CAS NO:1013695-97-0
Molecular Formula:
Molecular Weight: 441.895
EINECS: N/A
Product Categories: N/A
Mol File: 1013695-97-0.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[5-Chloro-6-(quinolin-3-yloxy)-pyridine-3-yl]-4-methoxy-benzenesulfonamide(CAS DataBase Reference)
NIST Chemistry Reference: N-[5-Chloro-6-(quinolin-3-yloxy)-pyridine-3-yl]-4-methoxy-benzenesulfonamide(1013695-97-0)
EPA Substance Registry System: N-[5-Chloro-6-(quinolin-3-yloxy)-pyridine-3-yl]-4-methoxy-benzenesulfonamide(1013695-97-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1013695-97-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1013695-97-0 Suppliers

Recommended suppliersmore

1013695-97-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1013695-97-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,3,6,9 and 5 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1013695-97:
(9*1)+(8*0)+(7*1)+(6*3)+(5*6)+(4*9)+(3*5)+(2*9)+(1*7)=140
140 % 10 = 0
So 1013695-97-0 is a valid CAS Registry Number.

1013695-97-0Upstream product

1013695-97-0Downstream Products

1013695-97-0Relevant articles and documents

METHOD FOR IDENTIFYING COMPOUNDS THAT ACT AS INSULIN-SENSITIZERS

-

, (2009/12/28)

The present invention relates to a method for identifying compounds that act as insulin-sensitizers. The method can include screening of test compounds in two assays of insulin sensitivity. This method can identify lead compounds for the treatment of disorders caused by insulin resistance to glucose uptake. This invention also includes methods for treating insulin resistance and related disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1013695-97-0